Yield10 Bioscience Inc

NASDAQ:YTEN   3:59:57 PM EDT
2.44
+0.16 (+7.02%)
Earnings Announcements

Yield10 Bioscience Announces Third Quarter 2022 Financial Results

Published: 11/14/2022 21:59 GMT
Yield10 Bioscience Inc (YTEN) - Yield10 Bioscience Announces Third Quarter 2022 Financial Results.
Yield10 Bioscience Inc - Yield10's Present Capital Resources Are Expected to Fund Its Planned Operations Into Q1 of 2023.
Yield10 Bioscience Inc - Qtrly Loss per Share $0.71.
Revenue is expected to be $0.12 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0.13 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.